image
Healthcare - Biotechnology - NASDAQ - US
$ 3.29
-4.64 %
$ 9.87 M
Market Cap
3.13
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-12.6 M OPERATING INCOME
-2.25%
-12.5 M NET INCOME
7.88%
EFFICIENCY
Earnings Waterfall Kiora Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 4.03 M
Gross Profit -4.03 M
Operating Expenses 12.6 M
Operating Income -12.6 M
Other Expenses -73 K
Net Income -12.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 12.1 K 2.7 1.7 0.4 0.7 0 0 0 0
GROSS PROFIT
Cost Of Revenue 4.0 0.1 0.2 0.2 4.89 K 8.1 10.3 8.4 1.26 K 0 0 0
Gross Profit (4.0) (0.1) (0.2) (0.2) 2.7 (6.4) (9.9) (7.8) 1.26 K 0 0 0
OPERATING INCOME
Operating Expenses 12.6 11.7 10.7 8.2 9.8 12.5 15.0 14.0 6.7 2.5 3.1 5.9
Selling, General and Administrative Expenses 4.7 8.3 5.3 4.7 4.4 4.4 4.6 5.6 4.0 1.9 2.1 2.8
Research and Development Expenses 5.9 3.4 5.4 3.6 5.4 8.1 10.3 8.4 2.7 0.5 1.0 3.0
Operating Income (12.6) (12.3) (16.9) (8.2) (7.0) (10.8) (14.6) (13.3) (6.7) (2.5) (3.1) (5.9)
PRE-TAX INCOME
Interest Income Expense 11.1 K 8.6 K 6.85 K 4.19 K 325 1.04 K 1.22 K 275 1.9 0.4 0.6 0
Total Other Income 0.2 (1.4) 0.3 19.2 K 0.1 0.1 91.7 K 3.41 K 1.0 0.7 (0.6) 11.1 K
Pre-Tax Income (12.4) (13.7) (16.7) (8.1) (7.0) (10.7) (14.6) (13.3) (8.4) (1.6) (3.7) (5.8)
NET INCOME
Tax Provision 90.3 K (0.1) (0.3) 12.1 K 95.4 K 86 K (1.3) 3.68 K 1.9 0.7 0.8 0.2
Net Income (12.5) (13.6) (16.4) (8.1) (7.1) (10.8) (13.2) (13.3) (8.4) (1.8) (3.9) (6.0)
EPS 24.2 18.6 68 70.5 89.2 183 556 906 817 153 436 679